Skip to main content
. 2013 Nov 23;209(8):1174–1184. doi: 10.1093/infdis/jit649

Table 2.

Cytokine and Chemokine Concentrations in Blood and Semen of Human Immunodeficiency Virus (HIV)-Uninfected, HIV-Infected (Antiretroviral [ARV]-naive), and HIV-infected (ARV-treated) Men

Cytokines/Chemokines Median Concentration (IQR)a
P Valueb
HIV-
Untreated
HAART+
Proinflammatory Blood Semen Blood Semen Blood Semen Blood Semen
 IL-1α - 16.3 (5.5–32.9) - 17.2 (5.3–79.3) - 17.4 (6.5–82) - 0.48
 IL-1β 0.15 (0.04–0.33) 0.25 (0.08–0.4) 0.26 (0.012–0.59) 0.17 (0.05–0.69) 0.09 (0.012–0.35) 0.32 (0.044–1) 0.14 0.82
 IL-6 6.5 (4–12.3) 32.5 (6.8–118.3) 6.6 (4–14.1) 22 (8.7–122) 5.5 (3.2–9.2) 33.4 (7.3–147.2) 0.67 0.98
 IL-8 2.3 (0.27–4.7) 1486 (241–2771) 2.5 (1.07–3.7) 1110 (643–2115) 2.8 (0.04–9.2) 1141 (540.5–2947) 0.8 0.86
 IL-12p40 5.4 (0.47–44.7) 2.8 (1.3–3.5) 0.47 (0.47–46.1) 1.9 (1.4–3.5) 0.47 (0.47–3.07) 3.1 (1.78–9.85) 0.21 0.2
 IL-12p70 0.01 (0.01–0.17) 0.05 (0.03–1.9) 0.01 (0.01–1.16) 0.036 (0.02–0.99) 0.01 (0.01–0.01) 1.2 (0.036–2.57) 0.39 0.21
 TNF-α 5.9 (4.6–7) 1.82 (0.79–4.5) 10.1 (7.02–12.5) 1.2 (0.57–3.95) 7.6 (6.4–9.8) 1.88 (0.27–5.9) 0.0003 0.88
 Eotaxin 89.1 (37.8–182.8) 23 (4.4–38.9) 89.2 (59–195.1) 16.3 (8.6–37.9) 49.8 (44.2–68.3) 28.2 (23.3–41.3) 0.083 0.28
 Fractalkine 42.6 (11.1–102.3) 802.9 (333–1636) 42.6 (18.8–82.4) 655.8 (251–1489) 0.59 (0.59–42.6) 875.6 (250–1019) 0.021 0.66
 MCP-1 216.7 (174.1–301.1) 14 110 (3908–31 028) 221.3 (168.4–364.7) 9805 (3211–18 029) 220.3 (155.2–303.8) 17 720 (7486–27 430) 0.72 0.18
 MIP-1α 1.95 (1.95–9.52) 3.15 (1.3–4.9) 1.95 (1.95–7.24) 7.5 (2.3–36) 1.95 (1.95–5.9) 15.7 (5.5–86.4) 0.67 0.013
 MIP-1β 8.7 (1.5–12.7) 78.1 (31.9–112.2) 3.01 (1.5–12.7) 53 (35.4–171.6) 5.1 (1.5–16.1) 83.4 (30.2–195.8) 0.85 0.92
 RANTES 2809 (1997–3156) 370.9 (189.2–649.3) 2663 (2080–3207) 266.5 (98.6–818.3) 2637 (2483–3332) 419.5 (178.6–1239) 0.97 0.56
 G-CSF 25.8 (15.5–47.8) 29.5 (12.2–60.5) 40.02 (24.6–53.2) 21.2 (7.5–84.3) 23.3 (15.5–30.7) 20 (12.9–58.1) 0.034 0.48
 GM-CSF 0.01 (0.01–0.86) 2.4 (0.65–7.35) 0.26 (0.01–0.69) 2.9 (1.6–6.2) 0.02 (0.01–0.69) 5.05 (2.1–14.7) 0.76 0.38
Regulatory
 IL-10 1.26 (0.88–2.02) 27.1 (7.1–52.4) 2.02 (1.26–2.8) 10.9 (2.02–17.5) 1.07 (0.88–1.5) 7.7 (0.8–24.5) 0.021 0.035
Adaptive
 IFN-γ 0.86 (0.37–2.9) 6.3 (2.7–21.9) 2.4 (0.86–7.8) 5.6 (1.9–10.2) 1.21 (0.37–1.33) 9.8 (0.78–40.5) 0.039 0.75
 IL-2 0.1 (0.01–0.98) 0.4 (0.03–2.56) 0.47 (0.05–1.39) 0.2 (0.026–1.22) 0.08 (0.01–0.86) 1.6 (0.022–3.52) 0.24 0.71
 IL-7 3.12 (1.27–7.44) 786.4 (395.9–1930) 3.13 (1.5–5.26) 715.8 (347–1865) 1.91 (0.54–4.9) 524.4 (414–2011) 0.43 0.8
 IL-15 0.37 (0.25–1.25) 27.8 (8.8–45.4) 0.25 (0.25–1.25) 27.6 (10.1–64.8) 0.25 (0.25–0.25) 30.7 (27.6–39.5) 0.065 0.74

Abbreviations: ARV, antiretroviral; G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte macrophage colony-stimulating factor; HIV, human immunodeficiency virus; IFN, interferon; IL, interleukin; IQR, interquartile range; MCP, monocyte chemotactic protein; MIP, macrophage inflammatory protein; RANTES, regulated upon activation normal T cell expressed and secreted; TNF, tumor necrosis factor.

a IQR, Interquartile range.

b P-value: Kruskal-Wallis significance between 3 groups.